Twist Bioscience Corporation (TWST)

NASDAQ: TWST · Real-Time Price · USD

145.59

+9.26 (6.79%)

At close: Aug 21, 2026, 4:00 PM EDT

144.50

-1.09 (-0.75%)

Pre-market: Aug 24, 2026, 8:54 AM EDT

Twist Bioscience Balance Sheet

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Cash & Equivalents	117.44	183.05	226.32	286.47	378.69	465.83
Short-Term Investments	49.4	49.39	50.08	49.94	126.28	12.03
Cash & Short-Term Investments	166.84	232.43	276.4	336.41	504.97	477.86
Cash Growth	-33.48%	-15.91%	-17.84%	-33.38%	5.67%	64.78%
Accounts Receivable	71.24	57.02	34.9	44.06	40.29	26.21
Other Receivables	-	-	-	-	-	2.34
Receivables	71.24	57.02	34.9	44.06	40.29	28.55
Inventory	35.16	28.31	24.08	32.06	39.31	31.8
Prepaid Expenses	9.96	15.2	11.4	11.72	11.91	8.28
Total Current Assets	321.3	332.97	346.78	424.26	596.48	546.5
Property, Plant & Equipment	180.62	151.66	161.35	203.36	214.39	105.7
Long-Term Investments	68.09	54.34	1.53	-	-	-
Goodwill	82.2	82.2	85.81	85.81	85.81	22.43
Other Intangible Assets	12.73	13.43	14.48	54.48	59.74	18.26
Other Long-Term Assets	5.55	5.48	4.38	8.49	4.96	6.18
Total Assets	672.44	641.86	614.32	776.4	961.38	702.1

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Accounts Payable	17.04	11.09	1.63	14.05	20.09	14.9
Accrued Expenses	55.33	54.34	48.75	36.57	37.19	28.76
Current Portion of Long-Term Debt	-	-	-	-	-	1.55
Current Portion of Leases	8.63	13.82	14.81	14.9	13.64	8.21
Current Income Taxes Payable	7.38	4.54	2.73	4.37	3.66	2.44
Current Unearned Revenue	6.47	6.88	2.13	3	3.48	1.09
Other Current Liabilities	25.41	0.72	0.96	0.43	12.6	6.1
Total Current Liabilities	120.26	91.41	71.01	73.32	90.66	63.05
Long-Term Debt	15	15	-	-	-	-
Long-Term Leases	84.96	61.75	70.22	79.17	81.27	53.16
Other Long-Term Liabilities	6.48	0.75	0.41	0.48	0.06	5.07
Total Liabilities	226.7	168.9	141.63	152.97	171.99	121.28

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Additional Paid-In Capital	1,876	1,793	1,715	1,657	1,620	1,191
Retained Earnings	-1,429	-1,320	-1,242	-1,033	-828.42	-610.55
Comprehensive Income & Other	-0.66	-0.63	-0.52	-0.76	-1.84	0.55
Total Common Equity	445.74	472.96	472.69	623.43	789.39	580.82
Shareholders' Equity	445.74	472.96	472.69	623.43	789.39	580.82
Total Liabilities & Equity	672.44	641.86	614.32	776.4	961.38	702.1

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Total Debt	108.59	90.57	85.03	94.07	94.91	62.92
Net Cash (Debt)	58.25	141.86	191.37	242.34	410.06	414.94
Net Cash Growth	-63.05%	-25.87%	-21.03%	-40.90%	-1.18%	63.35%
Net Cash Per Share	0.95	2.37	3.30	4.26	7.61	8.60
Filing Date Shares Outstanding	62.71	61.15	59.36	57.67	56.57	49.63
Total Common Shares Outstanding	62.67	60.63	58.88	57.56	56.52	49.5
Working Capital	201.04	241.56	275.77	350.93	505.82	483.44
Book Value Per Share	7.11	7.80	8.03	10.83	13.97	11.73
Tangible Book Value	350.81	377.34	372.4	483.14	643.84	540.13
Tangible Book Value Per Share	5.60	6.22	6.33	8.39	11.39	10.91
Machinery	121.07	107.88	105.93	111.18	67.43	53.61
Construction In Progress	19.55	20.12	4.69	8.53	87.72	16.97
Leasehold Improvements	68.54	58.28	57.45	57.27	14.37	5.07

SEC Filings: 10-K · 10-Q